novo nordisk semaglutide direct Launches Lower-Cost Wegovy, Following Eli Lilly Into Direct-to-Patient Sales Novo Nordisk secures FDA approval

Most state Medicaid programs cover Ozempic for type 2 diabetes with prior authorization, though requirements are often more stringent than commercial insurance

Because this isnt about willpower

Food and Drug Administration (FDA) approved Wegovy (the brand name for once-weekly Semaglutide 2.4 mg injection) for chronic weight management

This approach may reduce: Patients who follow the recommended escalation schedule often tolerate treatment more comfortably

However, if you have a formal diagnosis of Type 2 Diabetes and your doctor has explicitly prescribed it for glycemic control, a portion of the medication or diagnostic expenses may be claimable under specific corporate health plans or critical illness riders